György Miklós Buzás
A5033848244- Helicobacter pylori-related gastroenterology studies
- Gastroesophageal reflux and treatments
- Eosinophilic Esophagitis
- Gastric Cancer Management and Outcomes
- Enzyme function and inhibition
- Veterinary medicine and infectious diseases
- Microbial Metabolites in Food Biotechnology
- Gastrointestinal motility and disorders
- Celiac Disease Research and Management
- Digestive system and related health
- Gastrointestinal disorders and treatments
- Diet and metabolism studies
- Diet, Metabolism, and Disease
- Plant chemical constituents analysis
- Nutrition, Genetics, and Disease
- Vitamin K Research Studies
- Potassium and Related Disorders
- Phytochemical compounds biological activities
- Genetic factors in colorectal cancer
- Phenothiazines and Benzothiazines Synthesis and Activities
- Esophageal Cancer Research and Treatment
- Synthesis and Catalytic Reactions
- Cardiac, Anesthesia and Surgical Outcomes
- Health and Conflict Studies
- Cancer Research and Treatments
Fourmed Kft Gyógyház
2012-2023
BM Központi Kórház
2020-2022
University Gastroenterology
2020
Orszagos Kornyezetegeszsegugyi Intezet
2016
Hospital Universitario de La Princesa
2014
Gál Ferenc Főiskola
2004
Szent János Kórház
1994
The best approach for Helicobacter pylori management remains unclear. An audit process is essential to ensure clinical practice aligned with standards of care.International multicentre prospective non-interventional registry starting in 2013 aimed evaluate the decisions and outcomes H. by European gastroenterologists. Patients were registered an e-CRF AEG-REDCap. Variables included demographics, previous eradication attempts, prescribed treatment, adverse events outcomes. Data monitoring was...
INTRODUCTION: Antibiotic resistance is one of the main factors that determine efficacy treatments to eradicate Helicobacter pylori infection. Our aim was evaluate effectiveness first-line and rescue against H. in Europe according antibiotics resistance. METHODS: Prospective, multicenter, international registry on management (European Registry Management). All infected culture-diagnosed adult patients registered Spanish Association Gastroenterology-Research Electronic Data Capture from 2013...
Abstract Clarithromycin is a macrolide antibiotic widely used for eradication of Helicobacter pylori infection, and thus resistance to this major cause treatment failure. Here, we present the results retrospective observational study clarithromycin (Cla-res) in 4744 H. -infected patients from Central Hungary. We use immunohistochemistry fluorescence situ hybridization on fixed gastric tissue samples determine infection infer Cla-res status, respectively. correlate information with dispensing...
INTRODUCTION: The safety of Helicobacter pylori eradication treatments and to what extent adverse events (AEs) influence therapeutic compliance in clinical practice are hardly known. Our aim was assess the frequency, type, intensity, duration AEs, their impact on compliance, for most frequently used “European Registry management.” METHODS: Systematic prospective noninterventional registry European gastroenterologists (27 countries, 300 investigators) management H. infection routine practice....
Adherence to Helicobacter pylori (H. pylori) eradication treatment is a cornerstone for achieving adequate efficacy.
Abstract Background Conventional stainings (including H&E and special stains like Giemsa) are the most widely applied histopathologic detection methods of Helicobacter pylori ( HP ). Materials Methods We aimed to compare diagnostic performance Giemsa staining with immunohistochemistry IHC ) fluorescent in situ hybridization FISH on a monocentric cohort 2896 gastric biopsies relate results histologic alterations order find such subgroups which these underperform. All cases were...
Experience in Helicobacter pylori eradication treatment of patients allergic to penicillin is very scarce. A triple combination with a PPI, clarithromycin (C), and metronidazole (M) often prescribed as the first option, although more recently use quadruple therapy bismuth (B), tetracycline (T), M has been recommended.To evaluate efficacy safety first-line rescue treatments "European Registry H management" (Hp-EuReg).A systematic prospective registry clinical practice European...
Abstract Background Clarithromycin (Cla) heteroresistance of Helicobacter pylori ( H ) infections is commonly assessed by comparing the resistance status antrum and corpus biopsy samples demonstrating discrepancy between them (interniche heteroresistance). However, fluorescence in situ hybridization (FISH) technique capable showing synchronous presence susceptible resistant bacteria (intraniche heteroresistance), enabling detection heteroresistant populations within one sample. Materials...
The prevalence of Helicobacter pylori remains high in the older population. Specific age-related peculiarities may impact outcomes H. treatment. aim study was to evaluate diagnostics and effectiveness eradication between younger European populations. "European Registry on Management (Hp-EuReg)" data from 2013 2022 were analyzed. Patients divided into (≥ 60 years) (18-59 groups. Modified intention-to-treat (mITT) per-protocol (PP) analysis performed. 49,461 patients included which 14,467...
Several methods are available to diagnose Helicobacter pylori infection. Our objective was evaluate the tests used for both initial diagnosis and confirmation of eradication after treatment in Europe.The European Registry on management infection is an international, multicentre, prospective, non-interventional registry aiming pylori-infected patients Europe. Countries with at least 100 cases registered from June 2013 April 2021, a validated diagnostic method were analysed. Data quality...
AimTo assess the prevalence of Helicobacter pylori and viral co-infection in benign upper digestive diseases. MethodsOne hundred four outpatients were included a prospective endoscopic–serologic study. Epstein–Barr virus immunoglobulin G (IgG), M capsid antigen titres assayed with an ELISA test. was determined by modified Giemsa stain IgG-chemiluminescence. ResultsThe overall 56.7%. Duodenal ulcer patients infected 72.5 % cases, being 33.3% functional dyspepsia (p = 0.0008) 25.8% reflux...